AbbVie’s elagolix shows promise in uterine fibroids treatmentAbbVie’s elagolix has shown promise in a phase 2 trial in women with uterine fibroids, a second indication for Share XAbbVie’s elagolix shows promise in uterine fibroids treatmenthttps://pharmaphorum.com/news/abbvies-elagloix-shows-promise-uterine-fibroids-treatment/
